Login
Subscribecancer
A Master Regulator of Gene Expression
Mariella Bodemeier Loayza Careaga, PhD | Jan 31, 2024 | 4 min read
A CRISPR-based screening platform helped scientists identify a transcription factor that makes CAR T cells better at killing cancer cells.
Bugs as Drugs to Boost Cancer Therapy
Danielle Gerhard, PhD | Jan 18, 2024 | 7 min read
Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.
The Art and Science of Synthetic Biology
The Scientist | 2 min read
Researchers get creative using bacterial bits and pieces to produce synthetic cells for studying cancer.
Advanced Spatial Tools Map Hematopoietic Stem Cell Niches
Niki Spahich, PhD | Jan 15, 2024 | 4 min read
New technologies and archival tissue biopsy samples enable exploration of changes in the bone marrow as people age.
Hijacking Neurons’ Adaptive Abilities
Shelby Bradford, PhD | Jan 3, 2024 | 3 min read
Brain tumors use the brain’s plasticity to promote their own growth.
Aging and Cancer
Rebecca Roberts, PhD | 6 min read
The relationship between aging and cancer is complex, with several shared underlying mechanisms.
Building Biomolecular Machines
Danielle Gerhard, PhD | Jan 1, 2024 | 2 min read
William Shih draws inspiration from origami and jigsaw puzzles in his quest to build bigger DNA nanorobots.
Addressing Power and Pitfalls in Machine Learning Neoantigen Prediction
Deanna MacNeil, PhD | Dec 11, 2023 | 4 min read
Researchers honed prediction models and datasets to unlock the potential of deep neural networks in biological applications while avoiding bias.
Beyond Skin Deep: Analyzing Melanoma Cells Through Morphology
The Scientist | 1 min read
In this webinar, Evelyn Lattmann will discuss how she examined melanoma cell morphology without labels using an AI-based microscope system.
Mean, Green, Antibody-producing Machines
Shelby Bradford, PhD | Dec 1, 2023 | 2 min read
A plant-based monoclonal antibody goes head-to-head with its commercial counterpart to target tumors in mice.
The Christmas Mix-up
Danielle Gerhard, PhD | Dec 1, 2023 | 2 min read
In a rush to wrap up an experiment before the holidays, a slip of the hand almost ruined the festive mood for Cleo Parisi.
Unlocking the Secrets within Cells Using Next Generation Sequencing
The Scientist | 1 min read
Next generation sequencing (NGS) core facility scientists and researchers discuss their latest work exploring novel cancer models and stem cells in space.
Epigenetic Changes Drive Cancer
Rebecca Roberts, PhD | Nov 28, 2023 | 3 min read
An analysis of almost 700 different tumors revealed that DNA methylation drives tumorigenesis just like genetic mutations do.
A microRNA Family Drives the T Cell Response in Cancer
Niki Spahich, PhD | Nov 11, 2023 | 4 min read
When their in vitro and in vivo results conflicted, researchers took a deep dive into microRNAs’ influence on T cell memory formation.
How to Speed Up Cell Therapy Development Processes
The Scientist | 1 min read
In this webinar, Patrick Schmidt will explore how to streamline CAR T cell product manufacturing processes for immunotherapy.
Biosensors for Colorectal Cancer
Hannah Thomasy, PhD | Nov 1, 2023 | 4 min read
Engineered bacteria sound the alarm on a common oncogenic mutation.
Targeting Breast Cancer Metastasis
Tanvir Khan, PhD | Oct 16, 2023 | 3 min read
Researchers inhibited molecules that regulate both tumor and immune cell migration and their crosstalk signaling to impede metastasis.
New Strategies for Cancer Immunotherapy
The Scientist | 2 min read
An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer.
Mega Multiplexing for Exploring Diseased Tissues
Niki Spahich, PhD | Oct 16, 2023 | 4 min read
Researchers at KU Leuven specialize in performing a multiplex immunohistochemistry method that uses conventional antibodies and pathologist-driven data analysis.
Overcoming Cancer Therapy Obstacles With Epitope Editing
Rebecca Roberts, PhD | Oct 12, 2023 | 3 min read
Editing epitopes expressed on the surfaces of transplanted hematopoietic stem cells renders them resistant to AML treatments without affecting their critical functions.